Jazz Pharmaceuticals (JAZZ) Finished Goods (2010 - 2019)

Jazz Pharmaceuticals has reported Finished Goods for 10 years, with the latest figure at $22.3 million in Q1 2019.

• For the quarter ending Q1 2019, Finished Goods changed N/A year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2019 stood at $22.3 million (changed N/A YoY), and the FY2018 full-year result was $21.3 million, down 11.22% from the prior year.
• Finished Goods for Q1 2019 stood at $22.3 million, up from $21.3 million in the prior quarter.
• The five-year high for Finished Goods was $24.0 million in Q4 2017, with the low at $5.0 million in Q4 2015.
• Average Finished Goods over 5 years is $16.0 million, with a median of $17.9 million recorded in 2018.
• Year-over-year, Finished Goods slumped 69.83% in 2015 and surged 175.91% in 2016.
• Tracing JAZZ's Finished Goods over 5 years: stood at $5.0 million in 2015, then surged by 175.91% to $13.8 million in 2016, then soared by 73.8% to $24.0 million in 2017, then declined by 11.22% to $21.3 million in 2018, then gained by 4.68% to $22.3 million in 2019.
• The last three Finished Goods figures came in at $22.3 million (Q1 2019), $21.3 million (Q4 2018), and $17.9 million (Q2 2018), per Business Quant data.

Peer Comparison